Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Bettinger, D; Gkika, E; Schultheiss, M; Glaser, N; Lange, S; Maruschke, L; Buettner, N; Kirste, S; Nestle, U; Grosu, AL; Thimme, R; Brunner, TB.
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.
BMC Cancer. 2018; 18(1):807 Doi: 10.1186/s12885-018-4696-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Brunner Thomas Baptist
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: As stereotactic body radiation therapy (SBRT) has shown to be effective and safe in patients with hepatocellular carcinoma (HCC), the aim of our propensity score matched analysis was to evaluate the efficacy of SBRT in comparison to transarterial chemoembolization (TACE) in intermediate and advanced HCC. METHODS: Patients treated with TACE (n = 367) and patients allocated to SBRT (n = 35) were enrolled in this study. Propensity score matching was performed to adjust for differences in baseline and tumor characteristics of TACE and SBRT patients. Local tumor control (LC) 1 year after treatment, overall survival (OS) and 1-year mortality were assessed. RESULTS: Patients treated with SBRT have received more prior HCC treatments compared to TACE patients. The LC 1 year after treatment in the unmatched cohort was 74.4% for TACE patients compared to 84.8% in the SBRT group. Patients treated with TACE showed significantly improved OS (17.0 months vs. 9.0 months, p = 0.016). After propensity score matching, the LC in the TACE (n = 70) and SBRT (n = 35) group was comparable (82.9% vs. 84.8%, p = 0.805) and OS did not differ significantly in both groups. CONCLUSIONS: SBRT after prior HCC therapy in selected patients shows comparable LC at 1 year, OS and 1-year mortality compared to patients treated with TACE.
Find related publications in this database (using NLM MeSH Indexing)
Adult - administration & dosage
Aged - administration & dosage
Carcinoma, Hepatocellular - pathology, radiotherapy
Chemoembolization, Therapeutic - administration & dosage
Cohort Studies - administration & dosage
Combined Modality Therapy - administration & dosage
Female - administration & dosage
Humans - administration & dosage
Liver Neoplasms - pathology, radiotherapy
Male - administration & dosage
Middle Aged - administration & dosage
Propensity Score - administration & dosage
Radiosurgery - administration & dosage
Retrospective Studies - administration & dosage

Find related publications in this database (Keywords)
Hepatocellular carcinoma
Transarterial chemoembolization
Stereotactic body radiation therapy
Propensity score analysis
Overall survival
© Med Uni Graz Impressum